Defibrotide: a new antithrombotic agent
Bán, A.
Orvosi Hetilap 142(22): 1193-1194
2001
ISSN/ISBN: 0030-6002 PMID: 11424595 Document Number: 526848
Document emailed within 1 workday
Related Documents
DiMinno, G.; Silver, M.J. 1983: Mouse antithrombotic assay: a simple method for the evaluation of antithrombotic agents in vivo. Potentiation of antithrombotic activity by ethyl alcohol Journal of Pharmacology and Experimental Therapeutics 225(1): 57-60Han, B.H.; Suh, D.Y.; Yang, H.O.; Park, Y.H.; Kang, Y.H.; Kim, Y.C. 1994: Synthesis and antiplatelet effects of the new antithrombotic agent aspalatone with low ulcerogenicity Arzneimittel-Forschung 44(10): 1122-1126
Bajwa, S.S. 1981: A new type of antithrombotic agent: action of antithrombin IIi - factor Xa complex Proceedings of the Western Pharmacology Society 24: 275-279
Thiele, G.; Fiedler, H. 1973: Acetylsalicylic acid as antithrombotic agent in acute myocardial infarct without shock syndrome Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 28(3): 36-38 Passim
Pescador, R.; Porta, R.; Ferro, L. 1996: An integrated view of the activities of defibrotide Seminars in Thrombosis and Hemostasis 22(Suppl 1): 71-75
Pescador, R.; Porta, R.; Mantovani, M.; Prino, G. 1991: Cardioprotective effects of defibrotide: a minireview Seminars in Thrombosis and Hemostasis 17(Suppl 1): 96-100
Perotti, C.; Torretta, L.; Costamagna, L.; Salvaneschi, L. 1994: Thrombotic thrombocytopenic purpura after defibrotide therapy Haematologica 79(6): 569
Cimminiello, C. 1996: Clinical trials with defibrotide in vascular disorders Seminars in Thrombosis and Hemostasis 22(Suppl 1): 29-34
Marsili, M.; Lorenzi, P.; Librenti, M.; Doni, L.; Benassai, C.; Martini, E.; Fabbri, L.P.; Cinotti, S.; Morfini, M.; Boncinelli, S. 1989: Defibrotide in extracorporeal circulation on healthy rabbits International Journal of Artificial Organs 12(12): 749-754
Patrassi, G.M.; Sartori, M.T.; Viero, M.L.; Scapinello, M.P.; Boeri, G.; Girolami, A. 1991: Fibrinolytic effects of defibrotide in atherosclerotic patients Seminars in Thrombosis and Hemostasis 17(Suppl 1): 101-105
Di Perri, T.; Laghi Pasini, F.; Capecchi, P.L.; Ceccatelli, L.; Pasqui, A.L.; Orrico, A. 1987: Defibrotide in vitro inhibits neutrophil activation by a Ca++-involving mechanism International Journal of Tissue Reactions 9(5): 399-406
Buccianti, G.; Valenti, G.; Lorenz, M.; Cresseri, D.; Strada, E.; Nazzari, M. 1990: Kinetics of anti-Xa activity during combined defibrotide-heparin administration in hemodialysis International Journal of Artificial Organs 13(7): 416-420
Thiemermann, C.; Ney, P.; Schrör, K. 1988: Protection of the ischaemic myocardium from reperfusion injury by defibrotide and its possible mechanism of action Biomedica Biochimica Acta 47(10-11): S19-S22
Villani, L.G.; Dalla Valle, R.; Rubini, P. 1990: Defibrotide and heparin in the prevention of deep venous thromboses. A controlled study Minerva Chirurgica 45(15-16): 1029-1033
Palareti, G.; Guazzaloca, G.; Legnani, C.; Leali, N.; Busacchi, P.; Sani, G.; Levorato, M.; Di Marco, M.G.; Coccheri, S. 1992: Prophylaxis of venous thrombosis after gynaecological surgery: a controlled pilot study of defibrotide Haematologica 77(1): 44-48
Gerosa, C.; Calvani, A.B.; Cornelli, U.; Dina, F.; Ferrari, P.A.; Ratti, G.; Nazzari, M. 1989: A multicenter study of defibrotide in the prevention of deep venous thrombosis. Final results Minerva Chirurgica 44(10): 1507-1516
Bracciani, M.; Zanardi, R. 1989: Prevention of deep venous thrombosis in obstetrico-gynecologic surgery. Our experience with defibrotide Minerva Ginecologica 41(5): 225-229
Sabbá, C.; Zupo, V.; Dina, F.; Nazzari, M.; Albano, O. 1988: A pilot evaluation of the effect of defibrotide in patients affected by peripheral arterial occlusive disease International Journal of Clinical Pharmacology Therapy and Toxicology 26(5): 249-252
Yakushijin, K.; Matsui, T.; Okamura, A.; Yamamoto, K.; Ito, M.; Chihara, K. 2005: Successful treatment with defibrotide for sinusoidal obstruction syndrome after hematopoietic stem cell transplantation Kobe Journal of Medical Sciences 51(3-4): 55-65
Ranieri, G.; De Mitrio, V.; Petronelli, M.; Ancona, A.; Dammacco, F. 1988: Use of defibrotide in the treatment of Raynaud's phenomenon associated with progressive systemic sclerosis or essential mixed cryoglobulinemia La Clinica Terapeutica 126(5): 335-343